CompanyGraph
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
At a glance
- Depends onDownstream position: depends on 10 industries, supplies 5
- ScaleMarket cap is $245.37M, lower than 95% of all stocks globally
- FinancialsAltman Z-Score 14.3: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
What stands out
- Revenue is growing, but receivables have grown faster over the last six to eight years
Financials view
Market Capitalization
245.37MUSDvs all stocks (USD)
Revenue (TTM)
9.67MUSDvs all stocks (USD)
Beta
1.29xvs all stocks
52-Week Change
-49.40%vs all stocks
Market Capitalization
245.37MUSDvs all stocks (USD)
Enterprise Value
196.78MUSDvs all stocks (USD)
Forward P/E
11.16xPrice to Sales (TTM)
26.20xPrice to Book (MRQ)
3.60xEnterprise to Revenue
20.35xEnterprise to EBITDA
-5.25xGross Margin
4.19%Operating Margin
-242.00%Return on Assets (TTM)
-39.82%Return on Equity (TTM)
-77.16%Revenue (TTM)
9.67MUSDvs all stocks (USD)
Revenue per Share (TTM)
0.2430USDUpdated Jul 18, 2026Quarterly Revenue Growth
114.40%Gross Profit (TTM)
-298.00KUSDvs all stocks (USD)
EBITDA (TTM)
-37.50MUSDvs all stocks (USD)
Net Income (TTM)
-37.95MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
68.03%Operating Cash Flow (TTM)
-28.75MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
-17.74MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Minority Interest (Equity)
-1.55MUSDFY2025 · Dec 31, 2025Revenue
7.90MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
6.81MUSDFY2025 · Dec 31, 2025Gross Profit
1.09MUSDFY2025 · Dec 31, 2025Operating Income
-36.46MUSDvs all stocks (USD)
Pre-tax Income
-36.06MUSDFY2025 · Dec 31, 2025Net Income
-38.48MUSDFY2025 · Dec 31, 2025EBIT
-35.87MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-35.04MUSDFY2025 · Dec 31, 2025Research & Development
9.94MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
26.16MUSDFY2025 · Dec 31, 2025Other Operating Expenses
951.00KUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
185.00KUSDFY2025 · Dec 31, 2025EPS (Basic)
-1.03USDFY2025 · Dec 31, 2025EPS (Diluted)
-1.03USDFY2025 · Dec 31, 2025Basic Shares Outstanding
36.96MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
36.96MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-38.48MUSDFY2025 · Dec 31, 2025Minority Interests (P&L)
749.00KUSDFY2025 · Dec 31, 2025Operating Cash Flow
-22.43MUSDFY2025 · Dec 31, 2025Free Cash Flow
-22.88MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
13.53MUSDFY2025 · Dec 31, 2025Interest Paid
29.00KUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-38.48MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
815.00KUSDFY2025 · Dec 31, 2025Stock-based Compensation
20.36MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-5.03MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
3.01MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-3.10MUSDFY2025 · Dec 31, 2025Capital Expenditures
-452.00KUSDFY2025 · Dec 31, 2025Net Intangibles (CF)
-637.00KUSDFY2025 · Dec 31, 2025Net Acquisitions
-47.00KUSDFY2025 · Dec 31, 2025Purchase of Investments
-55.64MUSDFY2025 · Dec 31, 2025Other Investing Activity
-241.00KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
-56.38MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025Long-term Debt Payments
-1.55MUSDFY2025 · Dec 31, 2025Other Financing Charges
-1.85MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
62.32MUSDFY2025 · Dec 31, 2025Shares Outstanding
44.00MSharesUpdated Jul 18, 2026Float Shares
38.22MSharesUpdated Jul 18, 2026Shares Short
4.48MSharesUpdated Jul 18, 2026Short Ratio
13.20daysvs all stocks
Short % of Shares Outstanding
10.32%vs all stocks
% Held by Insiders
14.36%vs all stocks
% Held by Institutions
37.46%vs all stocks
Total Cash (MRQ)
57.34MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
1.29USDUpdated Jul 18, 2026Total Debt (MRQ)
2.42MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
0.0352xCurrent Ratio (MRQ)
10.57xBook Value per Share (MRQ)
1.58USDUpdated Jul 18, 2026Total Assets
85.16MUSDvs all stocks (USD)
Total Current Assets
79.41MUSDFY2025 · Dec 31, 2025Total Liabilities
8.74MUSDFY2025 · Dec 31, 2025Total Non-current Assets
5.75MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
1.79MUSDFY2025 · Dec 31, 2025Total Current Liabilities
6.95MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
13.53MUSDFY2025 · Dec 31, 2025Other Short-term Investments
56.03MUSDFY2025 · Dec 31, 2025Accounts Receivable
3.03MUSDFY2025 · Dec 31, 2025Inventory
3.89MUSDFY2025 · Dec 31, 2025Accounts Payable
3.35MUSDFY2025 · Dec 31, 2025Short-term Debt
828.00KUSDFY2025 · Dec 31, 2025Other Current Liabilities
576.00KUSDFY2025 · Dec 31, 2025Long-term Debt
1.79MUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-138.19MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
76.42MUSDvs all stocks (USD)
52-Week Low
4.97USDUpdated Jul 18, 202652-Week High
11.62USDUpdated Jul 18, 202652-Week Change
-49.40%vs all stocks
Beta
1.29xvs all stocks
50-Day MA
6.21USDUpdated Jul 18, 2026200-Day MA
6.53USDUpdated Jul 18, 2026Avg 10-Day Volume
210.31KSharesUpdated Jul 18, 2026Avg 30-Day Volume
291.40KSharesUpdated Jul 18, 2026Diluted EPS (TTM)
-0.9800USDUpdated Jul 18, 2026Other Income / Expense
-16.00KUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Diagnostic
High R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Heavy R&D and stock pay, with the share count growing across six years.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
Revenue is growing, but receivables have grown faster over the last six to eight yearsSignificant
Revenue Growth YoY: 1.14Receivables vs revenue divergence: 8.08
Financial Health
Altman Z-Score 14.3: safe zoneNotable
Altman Z-Score: 14.30
High structural barrier to entryNotable
Barrier to Entry: 3.10
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $245.37M, lower than 95% of all stocks globallySignificant
Market cap (USD): 245,372,223Global P5: 269,387,740.27
Revenue is $9.67M, lower than 95% of all stocks globallySignificant
Revenue (USD): 9,671,000Global P5: 30,274,777.221
Companies that share the same coordination system — how they create, deliver, or capture value.
BigCommerce Holdings Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Synagistics Limited
Tier 1InterfaceRecurring-Revenue Lock-InSenseMakingProduction
Commerce.com, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
PCA Corp.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Cafe24 Corp.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Gloo Holdings, Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionSenseMaking
Safie Inc.
Tier 1InterfaceRecurring-Revenue Lock-InFlowProduction
Dotdigital Group plc
Tier 1InterfaceRecurring-Revenue Lock-InProductionSenseMaking
Verve Group SE
Tier 1InterfaceRecurring-Revenue Lock-InAttentionFlow
Tasuki Holdings Inc.
Tier 1InterfaceRecurring-Revenue Lock-InProductionFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Wave Life Sciences Ltd.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
Eos Energy Enterprises Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC
IonQ, Inc.
1 interpretationHigh R&D Share With Multi-Year Share-Count Growth and Elevated SBC